DINOTO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.456
NA - Nord America 1.376
AS - Asia 1.278
SA - Sud America 246
AF - Africa 81
Totale 4.437
Nazione #
US - Stati Uniti d'America 1.317
RU - Federazione Russa 864
SG - Singapore 585
IT - Italia 224
CN - Cina 217
BR - Brasile 202
VN - Vietnam 152
HK - Hong Kong 121
GB - Regno Unito 75
DE - Germania 58
IE - Irlanda 47
KR - Corea 37
CA - Canada 36
BD - Bangladesh 34
FI - Finlandia 34
FR - Francia 31
IN - India 31
SE - Svezia 29
JP - Giappone 24
ZA - Sudafrica 22
AR - Argentina 20
NL - Olanda 18
TG - Togo 18
ID - Indonesia 16
BJ - Benin 15
PL - Polonia 15
MX - Messico 13
IQ - Iraq 12
AT - Austria 10
PK - Pakistan 8
TR - Turchia 8
UA - Ucraina 8
ES - Italia 7
NG - Nigeria 7
MA - Marocco 6
BE - Belgio 5
EC - Ecuador 5
LT - Lituania 5
PH - Filippine 5
CL - Cile 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
PE - Perù 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
LU - Lussemburgo 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
Totale 4.437
Città #
Singapore 326
Moscow 319
Ashburn 275
San Jose 239
Hong Kong 119
Dallas 91
Chandler 77
Verona 62
Ho Chi Minh City 57
Los Angeles 54
Beijing 50
Dublin 43
New York 41
The Dalles 39
Hanoi 35
London 29
Council Bluffs 25
Milan 23
Munich 23
São Paulo 23
Buffalo 21
Redondo Beach 19
Santa Clara 19
Lomé 18
Tokyo 17
Montreal 16
Cotonou 15
Warsaw 15
Helsinki 14
Orem 14
Lappeenranta 13
Phoenix 12
Rome 12
Johannesburg 11
Bologna 10
Denver 10
Haiphong 10
Jakarta 10
Da Nang 9
Frankfurt am Main 9
Mexico City 9
Naples 9
Chicago 8
Poplar 8
Toronto 8
Abuja 7
Florence 7
Amsterdam 6
Atlanta 6
Brooklyn 6
Cape Town 6
Chennai 6
Guangzhou 6
Houston 6
Kent 6
Lawrence 6
Princeton 6
Seattle 6
Stockholm 6
Washington 6
Brasília 5
Brussels 5
Campinas 5
Fortaleza 5
Kolkata 5
Nuremberg 5
Rio de Janeiro 5
Seoul 5
Sindelfingen 5
Treviso 5
Baghdad 4
Belo Horizonte 4
Boston 4
Bắc Ninh 4
Casablanca 4
City of London 4
Columbus 4
Pescara 4
Tianjin 4
Turku 4
Udine 4
Venice 4
Vienna 4
Xi'an 4
Bauru 3
Berlin 3
Bexley 3
Biên Hòa 3
Boardman 3
Brescia 3
Delhi 3
Guayaquil 3
Hyderabad 3
Lahore 3
Lima 3
Manassas 3
Manchester 3
Mumbai 3
Nova Iguaçu 3
Paris 3
Totale 2.512
Nome #
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 241
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 148
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 145
Is there a correlation between MOGAD and SARS-CoV-2 infection? 143
Autoimmune encephalitis misdiagnosis and mimics 142
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 135
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 129
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 126
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 125
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 122
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 121
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 119
Fatigue in Multiple Sclerosis: a resting-state EEG microstate study 118
Investigating the association between neoplasms and MOG antibody-associated disease 116
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 115
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 113
Autoimmune dementia 111
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 109
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 105
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 105
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 102
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 99
Complement activation profiles predict clinical outcomes in myelin oligodendrocyte glycoprotein antibody-associated disease 97
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder 96
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses 94
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 94
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 92
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 89
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 89
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? 88
Serum Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Correlate with Disease Severity in Patients with West Nile Virus Infection 85
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder 83
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis 81
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases 79
Diagnosing an unusual case of myelitis and diabetes insipidus through skin biopsies 79
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 78
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study 74
Treatment options in refractory autoimmune encephalitis 74
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 69
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 60
Autoimmune and paraneoplastic disorders of the nervous system 58
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease 49
Epstein-Barr virus infection in patients with MOGAD 48
Unveiling Disability Accrual Mechanisms in AQP4-IgG-Positive NMOSD 34
Validation of the MOG-AR Score: A Retrospective Multicenter Study 19
Neuroglial markers of damage in autoimmune neurology 4
Totale 4.502
Categoria #
all - tutte 16.616
article - articoli 16.471
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 145
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 0 0 0 0 2 13 9 7
2022/2023236 6 18 13 32 18 69 4 15 32 6 13 10
2023/2024294 12 15 23 30 21 48 14 25 12 14 56 24
2024/2025856 48 27 34 121 48 44 49 50 136 71 88 140
2025/20263.085 184 160 144 517 920 168 290 204 218 159 72 49
Totale 4.502